PPT-Prevention of cardiovascular risk in diabetes

Author : danika-pritchard | Published Date : 2017-04-10

Applying evidence based medicine to clinical care Cardiovascular disease is the biggest killer in UK Number of deaths 000s 124037 60666 18165 33634 16216 12762

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Prevention of cardiovascular risk in dia..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Prevention of cardiovascular risk in diabetes: Transcript

Applying evidence based medicine to clinical care Cardiovascular disease is the biggest killer in UK Number of deaths 000s 124037 60666 18165 33634 16216 12762 103431 19996. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . . البورد العربي . كلية طب الموصل . . . . 2011. . . PredictingHeart AttackandStroke risk Prevention of Cardiovascular DiseasePocket Guidelines for Assessment and Management of Cardiovascular Risk (WHO/ISH Cardiovascular Risk Prediction Charts for WHO e 1. Obesity. Management of Common Comorbidities in Diabetes. 2. 3. 4. More Than Two Thirds of US Adults Are Overweight or Obese. 5. *2014 rate of overweight not reported in . Flegal. et al 2016; 2012 rate carried over based on historic stability of overweight prevalence.. Aspirin in Primary Prevention, GLP-1 Agonists, Metformin, Psychotropic Drug Monitoring. Nathan Bertsch, PharmD. Mitchell Elting, MD. Most patients should not take aspirin for primary prevention of cardiovascular disease. Cyrus Desouza, MD. October 22, 2017. Why?. 1A. Evaluate the effect of vitamin D supplementation on incident CVD in people with . pre-diabetes.. 1B. . Establish CVD . risk in people with . pre-diabetes, defined by the modern ADA criteria.. Antidiabetes. Medications:. Cardiovascular Benefits. Hengameh. . Abdi. Endocrine Research Center. Research Institute for Endocrine sciences. Shahid. . Beheshti. University of Medical Sciences. 13 December 2018. MAHTAB NIROOMAND M.D.. Assistant professor of Endocrinology. SBUMS. Tehran 1391/11/19. . Out-line . Pathophysiology. and types of dyslipidemia in diabetic patients. Benefits of lipid- lowering therapy. David J Albrecht D.O.. Heart & Vascular 2018 Winter Conference. Cardiovascular risk . m. odification in relation to current diabetes management . therapies. Case study highlighting the therapeutic decisions . Jan - March 201 8 ; 5 ( 1 ): 2 3 - 2 9 Page 23 www.ijmse.com International Journal of Medical Science and Education An official Publication of Association for Scientific and Medical Education (ASME Nathan D. Wong, PhD, FACC, FAHA, FNLA, FASPC. Professor and Director. Heart Disease Prevention Program. Division of Cardiology. University of California, Irvine. Editorial Lead, ACC Diabetes and Cardiometabolic Clinical Topic Collection. Diabetes Care Begins With Diabetes Prevention. Housekeeping. . Please stay in listen-only mode. You may unmute when it’s time for Q/A. . This webinar will be recorded and shared via email. . If you have any questions, please type them in the Q/A box and we will address them during the Q/A session. . Sex . Male. Diabetes. . History. T2D, . onset. @45 . yrs. , treatment: . metformin. , . sitagliptin. and . gliclazide. . Organ. . damage. . evaluation. :. Eyes. : No . signs. of . retinopathy. January 24, 2023. Mary Pesik. Chronic Disease Prevention Program Director. Welcome. 2. Today’s Agenda. 3. 2023 Centers for Disease Control and Prevention (CDC) Notice of Funding Opportunities. Prediabetes and Diabetes. Farzad. . Hadaegh. , MD, . Professor of Internal Medicine & Endocrinology. Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences. Shahid. . Beheshti. University of Medical Sciences .

Download Document

Here is the link to download the presentation.
"Prevention of cardiovascular risk in diabetes"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.